Similarly, in experimental hyperaldosteronism, cardiac and renal fibrosis was associated with the expression of Gal3, which was prevented by Gal3 inhibitor MCP or genetic deletion of Gal3 (Calvier et al., 2015). Here, LGALS3 is linked to hyperaldosteronism.